James G. Stout

James G.
Stout worked as the Director of Purification Sciences at Amgen, Inc. from 2006 to 2010.
He then served as the Director of Process Science & Engineering at ImmunoGen, Inc. in 2012.
Prior to that, he was the Associate Director of Purification Development at Medarex, Inc. from 2001 to 2002.
James also held the position of Associate Director of Process Development at Shire US, Inc. He later became the Associate Director of Purification Process at Shire Human Genetic Therapies, Inc. from 2010 to 2012.
In 2018, he worked as the Director of Process Science Biologics at BioVectra, Inc. USA. James also worked as a Principal Scientist at Alexion Pharmaceuticals, Inc. He served as the Vice President of Process Sciences at Natrix Separations, Inc. from 2012 to 2017.
Additionally, he was the Group Leader of Purification Process Sciences at AbbVie Bioresearch Center, Inc. James held the position of Vice President of Glycobiologic Process Development at HOST Therabiomics from 2017 to 2018.
Currently, he is the Vice President of Chemistry, Manufacturing & Controls at Shattuck Labs, Inc. from 2020 to 2023.
Dr. Stout completed his undergraduate degree at Denison University.
He then pursued a doctorate degree at the University of Cincinnati (Ohio).